|1.||Efimova, E: 1 article (01/2010)|
|2.||Lovat, M: 1 article (01/2010)|
|3.||Groznaya, A: 1 article (01/2010)|
|4.||Trofimova, L: 1 article (01/2010)|
|5.||Maslova, M: 1 article (01/2010)|
|6.||Dunaeva, T: 1 article (01/2010)|
|7.||Graf, A: 1 article (01/2010)|
|8.||Bunik, V: 1 article (01/2010)|
|9.||Bunik, Victoria I: 1 article (02/2006)|
|10.||Santos, Sónia Sá: 1 article (02/2006)|
|1.||Brain Diseases (Brain Disorder)
01/01/2010 - "Remarkably, the hypoxia-induced elevation of brain OGDHC and most of the associated behavioral changes were abrogated by succinyl phosphonate. "
01/01/2010 - "In males treated with succinyl phosphonate and in pregnancy-sensitized females experiencing acute hypobaric hypoxia, we revealed upregulation of brain OGDHC (within 24 hours), with the activity increase presumably representing the compensatory response of brain to the OGDHC inhibition. "
01/01/2010 - "The antagonistic action of hypoxia and succinyl phosphonate demonstrates potential therapeutic significance of the OGDHC regulation by the phosphonate analogs of 2-oxoglutarate."
|2.||alpha-ketoglutaric acid (alpha-ketoglutarate)